chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pain
Clinical narrative: weakness; chills; body ache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), CHILLS (chills) and PAIN (body ache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ASTHENIA (weakness), CHILLS (chills) and PAIN (body ache). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, ASTHENIA (weakness), CHILLS (chills) and PAIN (body ache) was resolving.            No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pruritus, Swelling, Vaccination site erythema
Clinical narrative: Swelling; Redness; Tiredness; Itching; redness at injection site the size of an orange; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), ERYTHEMA (Redness), FATIGUE (Tiredness), PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (redness at injection site the size of an orange) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (redness at injection site the size of an orange). On an unknown date, the patient experienced SWELLING (Swelling), ERYTHEMA (Redness) and FATIGUE (Tiredness). At the time of the report, SWELLING (Swelling), ERYTHEMA (Redness), FATIGUE (Tiredness), PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (redness at injection site the size of an orange) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medication were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Paraesthesia, Pyrexia
Clinical narrative: fever; chills; aching; tingle in hands; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), PAIN (aching) and PARAESTHESIA (tingle in hands) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 029K2074) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills), PAIN (aching) and PARAESTHESIA (tingle in hands). At the time of the report, PYREXIA (fever), CHILLS (chills), PAIN (aching) and PARAESTHESIA (tingle in hands) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medication included Tylenol. No concomitant medications were provided by reporter.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Headache, Myalgia
Clinical narrative: dizzy; shaky; chills; achy muscles; achy joints; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), NERVOUSNESS (shaky), CHILLS (chills), MYALGIA (achy muscles) and ARTHRALGIA (achy joints) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and birth control for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (dizzy), NERVOUSNESS (shaky), CHILLS (chills), MYALGIA (achy muscles), ARTHRALGIA (achy joints) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), NERVOUSNESS (shaky), CHILLS (chills), MYALGIA (achy muscles), ARTHRALGIA (achy joints) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness
Clinical narrative: dizzy; shaky; chills; achy muscles; achy joints; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), NERVOUSNESS (shaky), CHILLS (chills), MYALGIA (achy muscles) and ARTHRALGIA (achy joints) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and birth control for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (dizzy), NERVOUSNESS (shaky), CHILLS (chills), MYALGIA (achy muscles), ARTHRALGIA (achy joints) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), NERVOUSNESS (shaky), CHILLS (chills), MYALGIA (achy muscles), ARTHRALGIA (achy joints) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pyrexia
Clinical narrative: Sore; Body aches; Chills; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Sore), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Sore), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event NOS, at a dose of 650 mg, once or twice daily. At the time of the report, PAIN (Sore), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN (Sore), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) to be possibly related.    No relevant concomitant medications were reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dysphagia, Oropharyngeal pain, Pain
Clinical narrative: Chills; Soreness; Pain in throat under chin; Hurts when he swallows; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PAIN (Soreness), OROPHARYNGEAL PAIN (Pain in throat under chin) and DYSPHAGIA (Hurts when he swallows) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills), PAIN (Soreness), OROPHARYNGEAL PAIN (Pain in throat under chin) and DYSPHAGIA (Hurts when he swallows). At the time of the report, CHILLS (Chills), PAIN (Soreness), OROPHARYNGEAL PAIN (Pain in throat under chin) and DYSPHAGIA (Hurts when he swallows) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medication were reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Worsening of her cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Worsening of her cough) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination.     Concurrent medical conditions included Chronic bronchitis and Sinusitis. Concomitant products included FLUTICASONE and IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (COMBIVENT) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced COUGH (Worsening of her cough). The patient was treated with GUAIFENESIN (MUCINEX) ongoing since an unknown date for Cough aggravated, at an unspecified dose and frequency. At the time of the report, COUGH (Worsening of her cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other treatment medications included: Essential oils (inhaled and drank on tea).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Injection site pain, Insomnia, Skin tightness
Clinical narrative: feels dizzy; bad soreness and pain at the injection site, specially at night; she cannot sleep; feels heavy; feels tight on top of where the injection site is; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (bad soreness and pain at the injection site, specially at night), INSOMNIA (she cannot sleep), HEADACHE (feels heavy), SKIN TIGHTNESS (feels tight on top of where the injection site is) and DIZZINESS (feels dizzy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE PAIN (bad soreness and pain at the injection site, specially at night), INSOMNIA (she cannot sleep), HEADACHE (feels heavy) and SKIN TIGHTNESS (feels tight on top of where the injection site is). On an unknown date, the patient experienced DIZZINESS (feels dizzy). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (bad soreness and pain at the injection site, specially at night), INSOMNIA (she cannot sleep), HEADACHE (feels heavy), SKIN TIGHTNESS (feels tight on top of where the injection site is) and DIZZINESS (feels dizzy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site erythema
Clinical narrative: Upper part of her arm is very sore; Upper part of her arm is red; Around the vaccine area is red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Upper part of her arm is very sore), ERYTHEMA (Upper part of her arm is red) and VACCINATION SITE ERYTHEMA (Around the vaccine area is red) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN IN EXTREMITY (Upper part of her arm is very sore), ERYTHEMA (Upper part of her arm is red) and VACCINATION SITE ERYTHEMA (Around the vaccine area is red). At the time of the report, PAIN IN EXTREMITY (Upper part of her arm is very sore), ERYTHEMA (Upper part of her arm is red) and VACCINATION SITE ERYTHEMA (Around the vaccine area is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral swelling, Pharyngeal swelling
Clinical narrative: Her throat started swelling; Arm swelling; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Her throat started swelling), PERIPHERAL SWELLING (Arm swelling) and FATIGUE (Fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Her throat started swelling), PERIPHERAL SWELLING (Arm swelling) and FATIGUE (Fatigue). On 25-Feb-2021, PHARYNGEAL SWELLING (Her throat started swelling) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm swelling) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medications included: Eye drops (not specified).  Treatment: None.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Hypertension, Nausea, Vaccination site pain
Clinical narrative: Dizzy 7 minutes after injection; High blood pressure 7 minutes after injection; Developed soreness in injected arm; Nausea 7 minutes after injection; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy 7 minutes after injection), HYPERTENSION (High blood pressure 7 minutes after injection), VACCINATION SITE PAIN (Developed soreness in injected arm) and NAUSEA (Nausea 7 minutes after injection) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) and LORAZEPAM (ATIVAN) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DIZZINESS (Dizzy 7 minutes after injection), HYPERTENSION (High blood pressure 7 minutes after injection), VACCINATION SITE PAIN (Developed soreness in injected arm) and NAUSEA (Nausea 7 minutes after injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy 7 minutes after injection), HYPERTENSION (High blood pressure 7 minutes after injection), VACCINATION SITE PAIN (Developed soreness in injected arm) and NAUSEA (Nausea 7 minutes after injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Heart rate: 160 (High) 7 minutes after injection, felt heart rate jump (increased).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Injection site pain, Pain in extremity
Clinical narrative: extremely tired; left arm was killing her; injection site pain; Sharp pain in shoulder blade; Felt lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection site pain), ARTHRALGIA (Sharp pain in shoulder blade), DIZZINESS (Felt lightheaded), FATIGUE (extremely tired) and PAIN IN EXTREMITY (left arm was killing her) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE PAIN (injection site pain), ARTHRALGIA (Sharp pain in shoulder blade), DIZZINESS (Felt lightheaded) and PAIN IN EXTREMITY (left arm was killing her). On an unknown date, the patient experienced FATIGUE (extremely tired). At the time of the report, INJECTION SITE PAIN (injection site pain), ARTHRALGIA (Sharp pain in shoulder blade), DIZZINESS (Felt lightheaded), FATIGUE (extremely tired) and PAIN IN EXTREMITY (left arm was killing her) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, Wound haemorrhage
Clinical narrative: it was a very itchy rash; on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed; on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (it was a very itchy rash), PRURITUS (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) and WOUND HAEMORRHAGE (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Previously administered products included for Drug allergy: penicillin since an unknown date. Concurrent medical conditions included Drug allergy (Tylenol, advil). Concomitant products included HYDROCHLOROTHIAZIDE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (it was a very itchy rash), PRURITUS (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) and WOUND HAEMORRHAGE (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed). At the time of the report, RASH PRURITIC (it was a very itchy rash), PRURITUS (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) and WOUND HAEMORRHAGE (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treated with itch medicine and steroids shot.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Vaccination site pain
Clinical narrative: chills;Soreness (injection site); A spontaneous report was received from a consumer concerning a 62-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills/ chills and soreness (injection site)/vaccination site pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Mar 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 002A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 3 Mar 2021, the patient experienced Chills and Soreness (injection site).  No treatment information was provided..  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events chills and soreness (injection site) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, COVID-19, Disorientation, Dizziness
Clinical narrative: Covid symptom; Bone aches; A little rapid heart rate; Disoriented; Ringing in the ears; Dizzy; Headache/weird COVID headache; Joint aches; Right arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (A little rapid heart rate), VACCINATION SITE PAIN (Right arm hurt), DISORIENTATION (Disoriented), TINNITUS (Ringing in the ears) and DIZZINESS (Dizzy) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Shingles. Concomitant products included GABAPENTIN for Shingles.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Right arm hurt). On 28-Feb-2021, the patient experienced DISORIENTATION (Disoriented), TINNITUS (Ringing in the ears), DIZZINESS (Dizzy), HEADACHE (Headache/weird COVID headache) and ARTHRALGIA (Joint aches). On 01-Mar-2021, the patient experienced TACHYCARDIA (A little rapid heart rate) and BONE PAIN (Bone aches). On an unknown date, the patient experienced COVID-19 (Covid symptom). On 01-Mar-2021, VACCINATION SITE PAIN (Right arm hurt), DISORIENTATION (Disoriented), TINNITUS (Ringing in the ears), DIZZINESS (Dizzy) and ARTHRALGIA (Joint aches) had resolved, HEADACHE (Headache/weird COVID headache) was resolving. At the time of the report, TACHYCARDIA (A little rapid heart rate) and COVID-19 (Covid symptom) had resolved and BONE PAIN (Bone aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.   This case was linked to MOD-2021-274389 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Outcome & dose 2 information updated
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Tachycardia, Tinnitus, Vaccination site pain
Clinical narrative: Covid symptom; Bone aches; A little rapid heart rate; Disoriented; Ringing in the ears; Dizzy; Headache/weird COVID headache; Joint aches; Right arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (A little rapid heart rate), VACCINATION SITE PAIN (Right arm hurt), DISORIENTATION (Disoriented), TINNITUS (Ringing in the ears) and DIZZINESS (Dizzy) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Shingles. Concomitant products included GABAPENTIN for Shingles.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Right arm hurt). On 28-Feb-2021, the patient experienced DISORIENTATION (Disoriented), TINNITUS (Ringing in the ears), DIZZINESS (Dizzy), HEADACHE (Headache/weird COVID headache) and ARTHRALGIA (Joint aches). On 01-Mar-2021, the patient experienced TACHYCARDIA (A little rapid heart rate) and BONE PAIN (Bone aches). On an unknown date, the patient experienced COVID-19 (Covid symptom). On 01-Mar-2021, VACCINATION SITE PAIN (Right arm hurt), DISORIENTATION (Disoriented), TINNITUS (Ringing in the ears), DIZZINESS (Dizzy) and ARTHRALGIA (Joint aches) had resolved, HEADACHE (Headache/weird COVID headache) was resolving. At the time of the report, TACHYCARDIA (A little rapid heart rate) and COVID-19 (Covid symptom) had resolved and BONE PAIN (Bone aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.   This case was linked to MOD-2021-274389 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Outcome & dose 2 information updated
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Chest is closing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest is closing) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 013M20A) for COVID-19 vaccination.     The patient's past medical history included Lung cancer since 2016.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHEST DISCOMFORT (Chest is closing). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Chest is closing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Metrol Dose Pack .
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: Rash - Near Injection site; Arm Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash - Near Injection site) and PAIN IN EXTREMITY (Arm Pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 207M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash - Near Injection site) and PAIN IN EXTREMITY (Arm Pain). On 03-Mar-2021, VACCINATION SITE RASH (Rash - Near Injection site) and PAIN IN EXTREMITY (Arm Pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medication were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site pain, Secretion discharge
Clinical narrative: Pain at the injection site; Hardness at the injection site; Patient reported that when she woke up, she noticed a green color film like mucous and spit it out; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at the injection site), INJECTION SITE INDURATION (Hardness at the injection site) and SECRETION DISCHARGE (Patient reported that when she woke up, she noticed a green color film like mucous and spit it out) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE PAIN (Pain at the injection site), INJECTION SITE INDURATION (Hardness at the injection site) and SECRETION DISCHARGE (Patient reported that when she woke up, she noticed a green color film like mucous and spit it out). At the time of the report, INJECTION SITE PAIN (Pain at the injection site), INJECTION SITE INDURATION (Hardness at the injection site) and SECRETION DISCHARGE (Patient reported that when she woke up, she noticed a green color film like mucous and spit it out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Dry mouth, Pruritus, Thirst, Urticaria
Clinical narrative: yellow bruising on arm; welt; some heat; itching; dry mouth; unquenchable thirst; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), THIRST (unquenchable thirst), CONTUSION (yellow bruising on arm), URTICARIA (welt) and VACCINATION SITE WARMTH (some heat) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DRY MOUTH (dry mouth) and THIRST (unquenchable thirst). On 23-Feb-2021, the patient experienced URTICARIA (welt), VACCINATION SITE WARMTH (some heat) and PRURITUS (itching). On an unknown date, the patient experienced CONTUSION (yellow bruising on arm). On 16-Feb-2021, DRY MOUTH (dry mouth) and THIRST (unquenchable thirst) had resolved. At the time of the report, CONTUSION (yellow bruising on arm), URTICARIA (welt), VACCINATION SITE WARMTH (some heat) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: yellow bruising on arm; welt; some heat; itching; dry mouth; unquenchable thirst; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), THIRST (unquenchable thirst), CONTUSION (yellow bruising on arm), URTICARIA (welt) and VACCINATION SITE WARMTH (some heat) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DRY MOUTH (dry mouth) and THIRST (unquenchable thirst). On 23-Feb-2021, the patient experienced URTICARIA (welt), VACCINATION SITE WARMTH (some heat) and PRURITUS (itching). On an unknown date, the patient experienced CONTUSION (yellow bruising on arm). On 16-Feb-2021, DRY MOUTH (dry mouth) and THIRST (unquenchable thirst) had resolved. At the time of the report, CONTUSION (yellow bruising on arm), URTICARIA (welt), VACCINATION SITE WARMTH (some heat) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Pain, Pain in extremity
Clinical narrative: numbness; numbness; ache on the left side of her face; ache on the left side of her face; aches in her arm; general mild achiness; headache; fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (aches in her arm), PAIN (general mild achiness), the first episode of PAIN (ache on the left side of her face) and the first episode of HYPOAESTHESIA (numbness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (aches in her arm), PAIN (general mild achiness) and HEADACHE (headache). On 21-Feb-2021, the patient experienced the first episode of PAIN (ache on the left side of her face) and the second episode of PAIN (ache on the left side of her face). On 24-Feb-2021, the patient experienced the first episode of HYPOAESTHESIA (numbness) and the second episode of HYPOAESTHESIA (numbness). The patient was treated with Ibuprofen at an unspecified dose and frequency. On 21-Feb-2021, PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (aches in her arm), PAIN (general mild achiness) and HEADACHE (headache) had resolved. On 22-Feb-2021, FATIGUE (fatigue) had resolved. On 24-Feb-2021, last episode of PAIN (ache on the left side of her face) had resolved. At the time of the report, last episode of HYPOAESTHESIA (numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information were not provided by the reporter.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine with aura, Visual impairment, Vitreous floaters
Clinical narrative: unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed; eye doctor made a diagnosis of ocular migraine; unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VISUAL IMPAIRMENT (unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed), MIGRAINE WITH AURA (eye doctor made a diagnosis of ocular migraine) and VITREOUS FLOATERS (unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISUAL IMPAIRMENT (unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed), MIGRAINE WITH AURA (eye doctor made a diagnosis of ocular migraine) and VITREOUS FLOATERS (unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed). At the time of the report, VISUAL IMPAIRMENT (unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed), MIGRAINE WITH AURA (eye doctor made a diagnosis of ocular migraine) and VITREOUS FLOATERS (unusual visual disturbance/ see a circle in the center of vision/ jagged line that he could see with eyes open and closed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: slight rash about 2 inches below the injection site, rash probably the size of a half a coffee cup; redness; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE RASH (slight rash about 2 inches below the injection site, rash probably the size of a half a coffee cup) and VACCINATION SITE ERYTHEMA (redness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site). On 27-Feb-2021, the patient experienced VACCINATION SITE RASH (slight rash about 2 inches below the injection site, rash probably the size of a half a coffee cup) and VACCINATION SITE ERYTHEMA (redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itch, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE RASH (slight rash about 2 inches below the injection site, rash probably the size of a half a coffee cup) and VACCINATION SITE ERYTHEMA (redness) was resolving.            No concomitant medications provided.   This case was linked to MOD-2021-034925 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection site pink discoloration; injection site itching; injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (injection site pink discoloration), VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE SWELLING (injection site swelling) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (injection site pink discoloration), VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE SWELLING (injection site swelling). At the time of the report, VACCINATION SITE DISCOLOURATION (injection site pink discoloration), VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE SWELLING (injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Eye swelling, Headache, Mass excision, Muscle spasms
Clinical narrative: headache "almost like sinus headache"; hard lump; back part of her neck really bother; eyes are really bad, left eyes, she is having problem in her left eye; eyes swollen and itchy; left arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (eyes swollen and itchy), PAIN IN EXTREMITY (left arm hurt), HEADACHE (headache "almost like sinus headache"), MASS EXCISION (hard lump) and MUSCLE SPASMS (back part of her neck really bother) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced EYE SWELLING (eyes swollen and itchy) and PAIN IN EXTREMITY (left arm hurt). On an unknown date, the patient experienced HEADACHE (headache "almost like sinus headache"), MASS EXCISION (hard lump), MUSCLE SPASMS (back part of her neck really bother) and ASTHENOPIA (eyes are really bad, left eyes, she is having problem in her left eye). At the time of the report, EYE SWELLING (eyes swollen and itchy), PAIN IN EXTREMITY (left arm hurt), HEADACHE (headache "almost like sinus headache"), MASS EXCISION (hard lump), MUSCLE SPASMS (back part of her neck really bother) and ASTHENOPIA (eyes are really bad, left eyes, she is having problem in her left eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were thyroids pills. No treatment details were reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: headache "almost like sinus headache"; hard lump; back part of her neck really bother; eyes are really bad, left eyes, she is having problem in her left eye; eyes swollen and itchy; left arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (eyes swollen and itchy), PAIN IN EXTREMITY (left arm hurt), HEADACHE (headache "almost like sinus headache"), MASS EXCISION (hard lump) and MUSCLE SPASMS (back part of her neck really bother) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced EYE SWELLING (eyes swollen and itchy) and PAIN IN EXTREMITY (left arm hurt). On an unknown date, the patient experienced HEADACHE (headache "almost like sinus headache"), MASS EXCISION (hard lump), MUSCLE SPASMS (back part of her neck really bother) and ASTHENOPIA (eyes are really bad, left eyes, she is having problem in her left eye). At the time of the report, EYE SWELLING (eyes swollen and itchy), PAIN IN EXTREMITY (left arm hurt), HEADACHE (headache "almost like sinus headache"), MASS EXCISION (hard lump), MUSCLE SPASMS (back part of her neck really bother) and ASTHENOPIA (eyes are really bad, left eyes, she is having problem in her left eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were thyroids pills. No treatment details were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Feeling abnormal, Motion sickness
Clinical narrative: sudden feeling of motion sickness; disoriented; brain fog / felt more like shit; This spontaneous case was reported by a consumer and describes the occurrence of MOTION SICKNESS (sudden feeling of motion sickness), DISORIENTATION (disoriented) and FEELING ABNORMAL (brain fog / felt more like shit) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced MOTION SICKNESS (sudden feeling of motion sickness), DISORIENTATION (disoriented) and FEELING ABNORMAL (brain fog / felt more like shit). At the time of the report, MOTION SICKNESS (sudden feeling of motion sickness), DISORIENTATION (disoriented) and FEELING ABNORMAL (brain fog / felt more like shit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       water, taking walks used as Treatment
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pyrexia
Clinical narrative: Diarrhea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M2UA) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No medical history reported.).    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and PYREXIA (Fever). On 02-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, DIARRHOEA (Diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Injection site discomfort, Vertigo, Vertigo positional
Clinical narrative: Loss of balance persists; Loss of balance; Diagnosed with Benign Bilateral Positional Vertigo; Vertigo; Discomfort on injection arm; A spontaneous report was received on 25 Feb 2021, from a consumer concerning a 80-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events vertigo, loss of balance, discomfort on injection arm, diagnosed with benign bilateral positional vertigo, loss of balance persists.  The patient's medical history was not provided. Concomitant medications reported were High Blood Pressure Medications, Diabetes Medications, Cardiac Medications for drug use for unknown indication.  On 29 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 032L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 30 Jan 2021, the patient experienced the event(s) vertigo. On 30 Jan 2021, the patient experienced the event(s) loss of balance. On 30 Jan 2021, the patient experienced the event(s) discomfort on injection arm . On 7 Feb 2021, the patient experienced the event(s) diagnosed with benign bilateral positional vertigo. On 18 Feb 2021, the patient experienced the event(s) loss of balance persists.  Treatment details included Physical Therapy.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), vertigo was unknown.The outcome of event(s), loss of balance was unknown.The outcome of event(s), discomfort on injection arm was unknown.The outcome of event(s), diagnosed with benign bilateral positional vertigo. was unknown.The outcome of event(s), loss of balance persists was unknown.